Literature DB >> 23932394

A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?

Hans C Hasselbalch1.   

Abstract

A novel murine model for myeloproliferative neoplasms (MPNs) generated by overexpression of the transcription factor NF-E2 has recently been described. Sustained overexpression of NF-E2 in this model induced myeloid expansion with anemia, leukocytosis and thrombocytosis. Herein, it is debated if NF-E2 overexpression also might have induced a sustained state of in vivo leukocyte and platelet activation with chronic and self-perpetuating production of inflammatory products from activated leukocytes and platelets. If so, this novel murine model also may excellently describe the deleterious impact of sustained chronic NF-E2 overexpression during uncontrolled chronic inflammation upon the hematopoietic system--the development of clonal myeloproliferation. Accordingly, this novel murine model may also have delivered the proof of concept of chronic inflammation as a trigger and driver of clonal evolution in MPNs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic inflammation; Experimental inflammation model; Human inflammation model; IL-1beta; IL-6; IL-8; Myeloproliferative neoplasms; NF-E2 overexpression; NF-kappabeta activation; Reactive oxygen species (ROS); TNF-alpha

Mesh:

Substances:

Year:  2013        PMID: 23932394     DOI: 10.1016/j.leukres.2013.07.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells.

Authors:  Jadwiga J Gasiorek; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2015-02-27       Impact factor: 9.261

Review 2.  Practical murine hematopathology: a comparative review and implications for research.

Authors:  Karyn E O'Connell; Amy M Mikkola; Aaron M Stepanek; Andyna Vernet; Christopher D Hall; Chia C Sun; Eda Yildirim; John F Staropoli; Jeannie T Lee; Diane E Brown
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

Review 3.  Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Authors:  S Koschmieder; T I Mughal; H C Hasselbalch; G Barosi; P Valent; J-J Kiladjian; G Jeryczynski; H Gisslinger; J S Jutzi; H L Pahl; R Hehlmann; A Maria Vannucchi; F Cervantes; R T Silver; T Barbui
Journal:  Leukemia       Date:  2016-02-08       Impact factor: 11.528

4.  Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation.

Authors:  Hans Carl Hasselbalch; Vibe Skov; Thomas Stauffer Larsen; Mads Thomassen; Caroline Hasselbalch Riley; Morten K Jensen; Ole Weis Bjerrum; Torben A Kruse
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

5.  Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression.

Authors:  Hans Carl Hasselbalch; Mads Thomassen; Caroline Hasselbalch Riley; Lasse Kjær; Thomas Stauffer Larsen; Morten K Jensen; Ole Weis Bjerrum; Torben A Kruse; Vibe Skov
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

Review 6.  The Hen or the Egg: Inflammatory Aspects of Murine MPN Models.

Authors:  Jonas S Jutzi; Heike L Pahl
Journal:  Mediators Inflamm       Date:  2015-10-12       Impact factor: 4.711

7.  A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis.

Authors:  Vibe Skov; Mark Burton; Mads Thomassen; Thomas Stauffer Larsen; Caroline H Riley; Ann Brinch Madelung; Lasse Kjær; Henrik Bondo; Inger Stamp; Mats Ehinger; Rasmus Dahl-Sørensen; Nana Brochmann; Karsten Nielsen; Jürgen Thiele; Morten K Jensen; Ole Weis Bjerrum; Torben A Kruse; Hans Carl Hasselbalch
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

Review 8.  MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.

Authors:  Hans Carl Hasselbalch; Mads Emil Bjørn
Journal:  Mediators Inflamm       Date:  2015-10-28       Impact factor: 4.711

Review 9.  The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.

Authors:  Mads Emil Bjørn; Hans Carl Hasselbalch
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

10.  Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.

Authors:  Morten Andersen; Zamra Sajid; Rasmus K Pedersen; Johanne Gudmand-Hoeyer; Christina Ellervik; Vibe Skov; Lasse Kjær; Niels Pallisgaard; Torben A Kruse; Mads Thomassen; Jesper Troelsen; Hans Carl Hasselbalch; Johnny T Ottesen
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.